QUOTE AND NEWS
Forbes  Mar 4  Comment 
In trading on Wednesday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 1.9% on the day.  Components of that ETF showing particular strength include shares of Orexigen Therapeutics (OREX), up about 13.6% and shares of...
Forbes  Feb 27  Comment 
In trading on Friday, the Gold Miners ETF (GDX) is outperforming other ETFs, up about 2.2% on the day.  Components of that ETF showing particular strength include shares of Coeur Mining (CDE), up about 4.7% and shares of Buenaventura (BVN), up...
Forbes  Feb 17  Comment 
In trading on Tuesday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 1.5% on the day.  Components of that ETF showing particular strength include shares of Sarepta Therapeutics (SRPT), up about 11.7% and shares of Array...
Forbes  Feb 11  Comment 
In trading on Wednesday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 1.3% on the day.  Components of that ETF showing particular strength include shares of Sangamo Biosciences (SGMO), up about 16.2% and shares of Exelixis...
Forbes  Feb 2  Comment 
In trading on Monday, the SPDR S&P Oil & Gas Exploration & Production ETF (XOP) is outperforming other ETFs, up about 3.3% on the day.  Components of that ETF showing particular strength include shares of Comstock Resources (CRK), up about 15.8%...
Market Intelligence Center  Jan 28  Comment 
S&P Biotech SPDR (XBI) traded between $200.21 and $206.72 before closing at $204.67 Tuesday and presents some attractive trading opportunities today according to MarketIntelligenceCenter.com's patented algorithms. The computer program that picks...
Forbes  Jan 26  Comment 
In trading on Monday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 2.1% on the day.  Components of that ETF showing particular strength include shares of Ultragenyx Pharmaceutical (RARE), up about 9.2% and shares of...
Forbes  Jan 14  Comment 
In trading on Wednesday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 0.9% on the day.  Components of that ETF showing particular strength include shares of Ziopharm Oncology (ZIOP), up about 55% and shares of Intrexon...
Market Intelligence Center  Jan 12  Comment 
The patented algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center found a trading opportunity with S&P Biotech SPDR (XBI) that should provide a 5.71% return in just 67 days. Sell one Mar. '15 call at the $195.00...
Market Intelligence Center  Jan 8  Comment 
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered-call trade on S&P Biotech SPDR (XBI) that includes 5.79% downside protection. Sell one contract of the...




RELATED WIKI ARTICLES
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki